The College of Pharmacy’s third annual Biopharmaceutical Research and Development Symposium is set for Sept. 14-15 in the UNMC Center for Drug Discovery and Lozier Center for Pharmacy Sciences and Education. This year’s theme is “Research and Development of Nucleic Acid-Based Nanomedicines.”
Twelve invited speakers from academia, pharmaceutical industries, regulatory affairs (the Food and Drug Administration), and the National Institutes of Health (NIH), will discuss ways of rapidly turning nucleic acids and small molecules into effective nanomedicines.
These nucleic acid-based nanomedicines are beginning to be approved for clinical use, and successful collaboration between drug discovery and the pharmaceutical industry is essential in the development of new drugs.
In addition to the headline speakers, a handful of graduate students and postdocs also will be selected to give oral presentations. This symposium will provide a unique opportunity to faculty, postdocs, and graduate students of University of Nebraska campuses (UNMC, UNO, UNK and UNL), Creighton University and other nearby universities to have discussions with scientists from industries on the topics of mutual interest.
This symposium will highlight state-of-the-art practices in the pharmaceutical industry’s discovery and development of new drugs. It also will provide a guide to successful industry-academia collaboration with the opportunity to explore scale-up challenges and collaborate on how academia can more closely model industry-level pharmaceutical processes.
For more on the conference and to register, please click this link. For a list of speakers and their bios, go here.
Planning for the symposium was led by Ram Mahato, Ph.D., chair of pharmaceutical sciences, David Oupicky, Ph.D., co-director of the Center for Drug Delivery and Nanomedicine, and Jasmine Davda, Ph.D., an alumnus of UNMC and associate director of clinical pharmacology at Pfizer.